Gradient Investments LLC lowered its position in Evolent Health Inc (NYSE:EVH) by 8.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 41,292 shares of the technology company’s stock after selling 3,804 shares during the quarter. Gradient Investments LLC’s holdings in Evolent Health were worth $1,173,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. NumerixS Investment Technologies Inc bought a new position in shares of Evolent Health in the second quarter worth $105,000. Paloma Partners Management Co bought a new position in shares of Evolent Health in the second quarter worth $209,000. Brown Advisory Inc. bought a new position in shares of Evolent Health in the second quarter worth $210,000. Aperio Group LLC bought a new position in shares of Evolent Health in the second quarter worth $211,000. Finally, First Mercantile Trust Co. bought a new position in shares of Evolent Health in the second quarter worth $225,000.

Shares of NYSE:EVH opened at $25.44 on Friday. Evolent Health Inc has a 52-week low of $10.30 and a 52-week high of $29.05. The firm has a market capitalization of $2.23 billion, a P/E ratio of -36.37 and a beta of 1.19. The company has a quick ratio of 2.59, a current ratio of 2.59 and a debt-to-equity ratio of 0.12.

Evolent Health (NYSE:EVH) last announced its earnings results on Tuesday, August 7th. The technology company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.01. Evolent Health had a negative net margin of 9.84% and a negative return on equity of 1.82%. The company had revenue of $144.51 million during the quarter, compared to analyst estimates of $141.90 million. Sell-side analysts predict that Evolent Health Inc will post -0.36 EPS for the current year.

In other Evolent Health news, CEO Frank J. Williams sold 9,653 shares of the company’s stock in a transaction dated Wednesday, August 1st. The shares were sold at an average price of $19.97, for a total transaction of $192,770.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Thomas Peterson III sold 30,000 shares of the company’s stock in a transaction dated Thursday, August 30th. The shares were sold at an average price of $25.00, for a total transaction of $750,000.00. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 214,260 shares of company stock valued at $5,433,522. Company insiders own 4.82% of the company’s stock.

Several research analysts have recently weighed in on EVH shares. ValuEngine raised shares of Evolent Health from a “buy” rating to a “strong-buy” rating in a report on Friday, September 14th. Citigroup upped their target price on shares of Evolent Health from $25.00 to $32.00 and gave the stock a “buy” rating in a research report on Thursday, October 4th. Canaccord Genuity upped their target price on shares of Evolent Health from $24.00 to $28.00 and gave the stock a “buy” rating in a research report on Thursday, September 13th. Zacks Investment Research lowered shares of Evolent Health from a “hold” rating to a “sell” rating in a research report on Friday, August 10th. Finally, KeyCorp upped their target price on shares of Evolent Health from $26.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, August 20th. One investment analyst has rated the stock with a sell rating, thirteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $29.69.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Read More: Outstanding Shares

Want to see what other hedge funds are holding EVH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Evolent Health Inc (NYSE:EVH).

Institutional Ownership by Quarter for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.